Evidence map›Paper›PMID 27352916›Full record

ArticleJournal of evidence-based complementary & alternative medicine2017

Antidiabetic Mechanisms of Rosa canina Fruits: An In Vitro Evaluation.

Ali Fattahi, Fatemeh Niyazi, Behzad Shahbazi, Mohammad Hosein Farzaei, Gholamreza Bahrami

Open access · goldAbstract read
In one paragraph

Article in Journal of evidence-based complementary & alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Kinetic Modeling and Biological Activities ofAntioxidants (Basel, Switzerland) · 2025
    Article
  8. Review
  9. A Comprehensive Review on Phytochemistry and Pharmacology ofCurrent topics in medicinal chemistry · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Antidiabetic Potential ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  20. MechanisticPharmacognosy magazine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ali FattahiPharmaceutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Fatemeh NiyaziStudents Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Behzad ShahbaziPharmaceutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Mohammad Hosein FarzaeiPharmaceutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Gholamreza BahramiPharmaceutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran gbahrami@kums.ac.ir.
Kermanshah University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rosa canina fruits have been used traditionally for the treatment of diabetes mellitus and its complications. The aim of current study was to evaluate the in vitro mechanism of action of R canina in managing diabetes mellitus. Cell proliferation and cytotoxicity assay were performed on pancreatic β-cells, βTC6. The protective activity of the extract on streptozotocin-induced death in βTC6 cells was studied. The effect of R canina on the metabolism of glucose in HepG2, a hepatocellular carcinoma cell line, was evaluated. The effect of the extract on glucose diffusion across the dialysis membrane, which is a comfortable model for assessing cellular glucose absorption, was evaluated. The results obtained from current study confirmed that R canina extract can act as a growth factor for pancreatic β-cell line providing a novel mechanism for the observed antidiabetic effect of this natural agent. Further preclinical studies are necessary to evaluate the perfect mechanism of action of R canina in diabetes mellitus.

Indexed as

Cell LineCell ProliferationCell SurvivalDiabetes MellitusFruitHep G2 CellsHumansHypoglycemic AgentsMedicine, TraditionalPlant ExtractsRosaHypoglycemic AgentsPlant Extractscell proliferationdiabetes mellitusRosa caninatraditional medicine

Identifiers

PMID27352916
PMCPMC5871216
OpenAlexW2472150495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.